| Code | Description | Claims | Beneficiaries | Total Paid |
| J0178 |
Injection, aflibercept, 1 mg |
872 |
765 |
$735K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,385 |
3,075 |
$138K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
5,429 |
4,396 |
$92K |
| 92060 |
|
4,025 |
3,781 |
$89K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
3,684 |
2,981 |
$88K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
993 |
931 |
$82K |
| J9035 |
Injection, bevacizumab, 10 mg |
1,995 |
1,561 |
$68K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,047 |
1,811 |
$46K |
| 92134 |
|
5,336 |
4,448 |
$37K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
480 |
371 |
$37K |
| 92250 |
|
3,765 |
3,141 |
$31K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
378 |
361 |
$29K |
| 00142 |
|
701 |
539 |
$24K |
| 92235 |
|
1,161 |
1,006 |
$24K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
1,528 |
1,183 |
$20K |
| J7999 |
Compounded drug, not otherwise classified |
1,322 |
1,102 |
$16K |
| 92025 |
|
808 |
750 |
$10K |
| 92015 |
Determination of refractive state |
2,102 |
2,005 |
$9K |
| 92136 |
|
758 |
636 |
$7K |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
23 |
13 |
$6K |
| 92285 |
|
720 |
664 |
$6K |
| 92083 |
|
106 |
94 |
$1K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
13 |
12 |
$896.10 |
| 92242 |
|
17 |
14 |
$683.95 |
| 92133 |
|
38 |
30 |
$255.86 |
| 99072 |
|
876 |
824 |
$12.00 |
| 99152 |
|
29 |
26 |
$0.00 |